Login

Author: Brian Kangas

17 Jun

Posted at 16:02h in Publications by
0 Likes

ABSTRACT Challenges in therapeutics development for neuropsychiatric disorders can be attributed, in part, to a paucity of translational models capable of capturing relevant phenotypes across clinical populations and laboratory animals. Touch-sensitive procedures are increasingly used to develop innovative animal models that better align with testing conditions...

22 Oct

Posted at 13:57h in Publications by
0 Likes

Abstract Anhedonia, the loss of pleasure from previously rewarding activities, is implicated in several neuropsychiatric conditions, including major depressive disorder (MDD). In order to accelerate drug development for mood disorders, quantitative approaches are needed to objectively measure responsiveness to reward as a means to identify deficits....

X
Skip to toolbar